The company has launched a new chemical entity Lulifin (Luliconazole) in the Indian dermatology market, the pharma major said in a filing to the Bombay Stock Exchange.
Sardar Patel University offers a variety of postgraduate degree and diploma programmes.
Ranbaxy Laboratories Ltd, the country's biggest drug maker by revenues, has announced aggressive growth plans for the domestic market. It has increased its sales teams in specific areas like cardiovascular, diabetics and dermatology and plans to introduce over 100 new products by the year-end.
In another development, leading Japanese drug maker Takeda Pharmaceutical sued Ahmedabad-based Torrent Pharma in the US for infringing seven patents covering its flagship diabetes drug, Actos. Oracea (doxycycline) is the only US Food and Drug Administration approved oral drug to treat rosacea -- a skin disorder in the face with inflammation, skin redness and spider veins.
What do Asin, Megan Fox and Riya Sen all have in common? Their sexy, pouting lips. Dermatologist Dr Parul Kolhe gives tips to make your chops look as alluring.
This is the company's third international buyout in the last 12 months. Last year in October, the company had acquired Pinewood, the largest generic firm in Ireland and the biggest supplier of liquid generic products in the UK. Wockhardt had also bought Negma, the fourth largest independent pharmaceutical firm in France in May.
Medical PG Programmes at CMC, Vellore for December 1, 2003.
Systopic, a pharmaceutical organisation, is recruiting Product Managers and Product Executives.
Cymbiotics, a US-based bio-pharmaceutical manufacturer, has entered into a joint in-licensing agreement with Elder Pharmaceuticals to manufacture and market three of its drugs for pain management, diabetes and dermatology in the Indian market.
The Institute of Medical Sciences, Banaras Hindu University, invites application for admission to its MD/ MS programmes
Glenmark Pharmaceuticals Inc, has signed a $27 million royalty deal with international healthcare investment fund Paul Capital Partners' Royalty Fund to finance the development of 16 dermatological products by the pharma major for the US market.
Ranbaxy earned $114 million from its US operations in 2006. It launched 10 new products during the year. The company said that the revenues from the sale of the newly acquired brands would be reflected from the next quarter.
Tele/video-consults have been effective for patients requiring post-hospitalisation follow-up, especially if they are from outside the city; patients with chronic diseases that need periodic monitoring; and pregnant women who require routine checkup with minimum exposure.
Oily T-zone getting you down? Maybe you should try a face pack. Here are five packs specially for those suffering from an oily complexion.
Hydroxychloroquine has been identified by the US Food and Drug Administration as a possible treatment for the COVID-19 and it is being tested on more than 1,500 coronavirus patients in New York.
The proposed acquisition is expected to close by the end of 2014, subject to approvals from Indian Courts and the anti-trust body in India and the US
Get Ahead skincare expert Dr Parul Kolhe has the solutions for all your skin problems.
Have skin concerns? Send in your questions to Dr Dinesh Jain.
The Cabinet Committee on Economic Affairs has approved the proposal of GlaxoSmithKline Pte Limited, Singapore for acquisition of 24.33 per cent shares in existing Indian subsidiary company of GSK Group.
From rising prescriptions to the pharma sales force back on the field with full vigour and companies finally finding their feet with the digital marketing strategies - Indian drug makers have shown that medicine sales is certainly a sunshine sector.
The transaction is expected to be closed in the first quarter of the financial year.
In May, price growth for drugs was in negative territory at (-)1 per cent
While companies continue to face regulatory pressure leading to higher costs, they see an uptick from the launch of differentiated and high-margin products
Those who ditched the sun, a study has revealed, looked up to 20 years younger.
The AIIMS administration has initiated an internal inquiry to look into the cause of the fire and further strengthen preventive measure.
Work will never end, but one day our life will.
The Singapore subsidiary of the UK-based GlaxoSmithKline plans to buy 24.33 per cent stake or 2.06 crore equity shares in GlaxoSmithKline Pharmaceuticals Ltd through an open offer.
High humidity causes sweat, dirt and dust along with other toxins to build up on the surface of the skin. Dr Saumya Shetty Hegde tells you how to take care.
The company has received final approval for its supplemental New Drug Application (sNDA) for Antara (Fenofibrate) capsules in 30 mg and 90 mg strengths from the United States Food and Drug Administration (USFDA), Lupin Ltd said in a statement.
Increased price control over branded generic medicines has affected its profitability
What 32-year-old star Mandy Moore's actions tell us about anti-ageing regimes...
Are prisoners dying in Tamil Nadu jails due to lack of medical attention?
Companies that are developing biosimilars (for regulated markets) or have portfolio of new chemical entities (NCEs) under development.
The challenge of merging Ranbaxy into the company has not been factored in.
Lupin will fund the buy through $100 mn cash reserves and a bridge loan.
Markets snapped two-day losing streak and ended flat with a positive bias on Tuesday as gains in auto shares helped offset losses in IT majors.
